Viewing stories from May, 2012

31 May 2012
BRW: 9 Hot Tech Stocks

BRW Journalist Tony Featherstone profiled Starpharma as the #1 pick of the leading ASX tech stocks in his article, ‘9 hot tech stocks.

The Melbourne-based company is leading a pack of promising biotechs either in, or approaching, phase III trials for US Food and Drug Administration approval. Starpharma’s lead product, VivaGel, is being developed to treat bacterial vaginosis, where the normal balance of bacteria in the vagina is disrupted by an overgrowth of certain bacteria. If approved, VivaGel, a prescription product, would be applied daily to treat bacteria vaginosis and stop it reoccurring.

Read More

30 May 2012
The Business on ABC TV: Interview with Starpharma CEO Jackie Fairley

ABC News’ The Business Presenter Ticky Fullerton interviewed Starpharma CEO Dr Jackie Fairley on Wednesday 30th May 2012. Ticky discussed Starpharma’s valuable platform technology.

 

 Read the Transcript (external link)

Read More

Important Notice

This website is intended for people seeking information about Starpharma for investment and business purposes. This website contains information about products that may not be available, or approved, in all countries, or may be available under different trademarks, or for different indications. Individuals seeking information about a Starpharma product should visit the relevant product website in their country of residence or consult a healthcare provider. Nothing contained on this site should be considered a solicitation, promotion, or advertisement for any product, including those under development. Any information on this site is not intended to provide medical advice nor should be used as a substitute for the advice provided by a doctor or other healthcare provider.